188 related articles for article (PubMed ID: 37278102)
21. Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunotherapy efficacy.
Zhou P; Fu Y; Tang Y; Jiang L; Wang W
Lung Cancer; 2024 Mar; 189():107471. PubMed ID: 38306886
[TBL] [Abstract][Full Text] [Related]
22. Expanding the Immunophenotype Spectrum of SMARCA4-Deficient Non-Small Cell Lung Carcinomas: A Case Series with Neuroendocrine Markers Expression.
Mao R; Liu M; Shu X; Li W; Yan W; Li X
Int J Surg Pathol; 2022 May; 30(3):251-259. PubMed ID: 34633874
[No Abstract] [Full Text] [Related]
23. Thoracic SMARCA2-deficient But SMARCA4-preserved Tumors With Undifferentiated Morphology Combined With Claudin-4 Negativity.
Iwakoshi A; Sasaki E; Sato M; Sugiyama K; Kogure Y; Kitagawa C; Nishimura R
Am J Surg Pathol; 2022 Jul; 46(7):1000-1006. PubMed ID: 35220352
[TBL] [Abstract][Full Text] [Related]
24. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE
Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418
[TBL] [Abstract][Full Text] [Related]
25. A Subset of Thoracic SMARCA4-Deficient Undifferentiated Tumors Express GATA3.
Coconubo DM; Wangsiricharoen S; Pettus JR; Linos K; Pinto A; Wang WL; Kerr DA; Cloutier JM
Int J Surg Pathol; 2024 Jun; 32(4):684-691. PubMed ID: 37461275
[TBL] [Abstract][Full Text] [Related]
26. Under the Microscope: A Case Report of Thoracic SMARCA4-Deficient Undifferentiated Tumor with Review of the Literature.
Mundada M; Mannan KA; Vasu D; Ahmed F; K S
Turk Patoloji Derg; 2024; 40(2):128-133. PubMed ID: 38265099
[TBL] [Abstract][Full Text] [Related]
27. SMARCA4-deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report.
Utsumi T; Taniguchi Y; Noda Y; Fukai M; Kibata K; Murakawa T
Thorac Cancer; 2022 Aug; 13(15):2264-2266. PubMed ID: 35778998
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.
Yoshida A; Kobayashi E; Kubo T; Kodaira M; Motoi T; Motoi N; Yonemori K; Ohe Y; Watanabe SI; Kawai A; Kohno T; Kishimoto H; Ichikawa H; Hiraoka N
Mod Pathol; 2017 Jun; 30(6):797-809. PubMed ID: 28256572
[TBL] [Abstract][Full Text] [Related]
29. Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors.
Matsushita M; Kuwamoto S
Acta Cytol; 2018; 62(5-6):456-462. PubMed ID: 30286456
[TBL] [Abstract][Full Text] [Related]
30. NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumour: facts and controversies.
Yoshida A
Histopathology; 2024 Jan; 84(1):86-101. PubMed ID: 37873676
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic Tumor.
Shinno Y; Yoshida A; Masuda K; Matsumoto Y; Okuma Y; Yoshida T; Goto Y; Horinouchi H; Yamamoto N; Yatabe Y; Ohe Y
Clin Lung Cancer; 2022 Jul; 23(5):386-392. PubMed ID: 35618627
[TBL] [Abstract][Full Text] [Related]
32. SMARCA4-deficient non-small cell lung carcinoma: clinicodemographic, computed tomography, and positron emission tomography-computed tomography features.
Kim JH; Woo JH; Lim CY; An T; Han J; Chung MJ; Cha YK
J Thorac Dis; 2024 Mar; 16(3):1753-1764. PubMed ID: 38617754
[TBL] [Abstract][Full Text] [Related]
33. SMARCA4 as a support for the differential diagnosis of poorly differentiated lung carcinomas.
Panozzi M; Alì G; Proietti A; Melfi F; Zirafa CC; Lucchi M; Fontanini G
Pathologica; 2023 Jun; 115(3):164-171. PubMed ID: 37387441
[TBL] [Abstract][Full Text] [Related]
34. Fine needle aspiration cytology of metastatic SMARCA4-deficient sinonasal teratocarcinosarcoma: First report in literature.
Gopakumar A; Kakkar A; Kaur K; Sikka K; Thakar A; Sharma A; Jain D
Diagn Cytopathol; 2023 Apr; 51(4):E129-E136. PubMed ID: 36680532
[TBL] [Abstract][Full Text] [Related]
35. SWI/SNF-deficient thoraco-pulmonary neoplasms.
Sesboue C; Le Loarer F
Semin Diagn Pathol; 2021 May; 38(3):183-194. PubMed ID: 33451916
[TBL] [Abstract][Full Text] [Related]
36. SMARCA4-Deficient Undifferentiated Tumor Diagnosed on Adrenal Sampling.
Ashour S; Reynolds JP; Mukhopadhyay S; McKenney JK
Am J Clin Pathol; 2022 Jan; 157(1):140-145. PubMed ID: 34463317
[TBL] [Abstract][Full Text] [Related]
37. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
[TBL] [Abstract][Full Text] [Related]
38. SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.
Herpel E; Rieker RJ; Dienemann H; Muley T; Meister M; Hartmann A; Warth A; Agaimy A
Ann Diagn Pathol; 2017 Feb; 26():47-51. PubMed ID: 28038711
[TBL] [Abstract][Full Text] [Related]
39. SMARCA4-Deficient Undifferentiated Tumor of Lung Mass-A Rare Tumor With the Rarer Occurrence of Brain Metastasis: A Case Report and Review of the Literature.
Yadav R; Sun L; Salyana M; Eric M; Gotlieb V; Wang JC
J Investig Med High Impact Case Rep; 2022; 10():23247096221074864. PubMed ID: 35356840
[TBL] [Abstract][Full Text] [Related]
40.
Nakra T; Kakkar A; Mathur SR; Jain D; Kumar S
Int J Surg Pathol; 2023 Feb; 31(1):104-109. PubMed ID: 35466749
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
